ETON
Eton Pharmaceuticals Stock Analysis
AI Rating
- Quality1/10
- Growth↓ 4/10
- Value↓ 1/10
ETON Growth
- Revenue Y/Y↑ 105.63%
- EPS Y/Y↓ -13.33%
- FCF Y/Y↑ 980.70%
ETON Profitability
- Gross margin ↑ 53.90%
- EPS margin↓ -5.70%
- ROIC 5Y↓ -43.13%
ETON Risk
- Debt / Equity↓ 1.2
- Debt / FCF↓ 0.5
- Interest coverage↓ -0.2
Eton Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.